基于外周血T淋巴细胞比例特点的慢加急性肝衰竭正虚机制

曹慧; 张旸; 谭善忠; 赵磊; 沈建军; 肖倩; 梁重峰; 蒋淑莲

doi:10.3969/j.issn.1001-5256.2014.04.009

基于外周血T淋巴细胞比例特点的慢加急性肝衰竭正虚机制

DOI: 10.3969/j.issn.1001-5256.2014.04.009

1. 南京市第二医院中西医结合科
2. 南京中医药大学临床医学院

基金项目:

南京市医学科技发展项目(DYY056,ZKX13018)；南京市科技计划项目(201104004)；江苏省“六大人才高峰”项目(苏人社发〔2010〕555号)；江苏省中医药领军人才项目(LJ200922)；江苏省“333高层次人才培养工程”项目(苏人才〔2011〕15号)；

详细信息

中图分类号: R512.62;R575.3
计量
- 文章访问数: 2753
- HTML全文浏览量: 17
- PDF下载量: 516
- 被引次数: 0
出版历程
- 收稿日期: 2013-07-29
- 出版日期: 2014-04-20

Relationship between percentages of T lymphocytes in peripheral blood and deficiency of vital qi in patients with HBV- ACLF

Department of Integrated , TCM & Western Medicine, The Second Hospital of Nanjing

Research funding:

摘要

摘要:
目的探讨外周血T淋巴细胞比例特点与HBV相关慢加急性肝衰竭正虚机制的关系。方法选取2010年1月-2012年12月在本院就诊的HBV相关慢加急性肝衰竭早期患者（肝衰竭组）40例与慢性乙型肝炎（CHB）患者（CHB组）50例,以门诊同期健康体检者20例为健康对照组,应用流式细胞仪测定外周血CD3+T淋巴细胞、CD4+和CD8+T淋巴细胞比值、CD4+CD25+调节性T细胞所占比例,比较组间差异。3组间比较采用方差分析。结果肝衰竭组外周血CD3+T淋巴细胞（34.12%±22.33%）、CD4+/CD8+比值（1.78±1.25）和CD4+CD25+调节性T细胞（0.83%±1.00%）所占比例与健康对照组（分别为50.31%±12.09%、1.32%±0.31%、2.93%±1.31%）和CHB组（分别为49.72%±20.11%、1.31%±0.52%、3.17%±2.29%）相比较均下降,差异有统计学意义（P<0.05）。结论 HBV相关慢加急性肝衰竭一旦形成,外周血T淋巴细胞及相关效应T淋巴细胞便处于"耗损"状态,体现其"正虚"的病机特点。
- 肝功能衰竭 /
- 肝炎,乙型,慢性 /
- T淋巴细胞 /
- 中西医结合疗法
Abstract:
Objective To investigate the relationship between percentages of T lymphocytes in peripheral blood and deficiency of vital qi in patients with hepatitis B virus- related acute- on- chronic liver failure (HBV- ACLF) .Methods Forty patients with early- stage HBV-ACLF were enrolled as liver failure group, and 50 patients with chronic hepatitis B (CHB) as CHB group;20 healthy subjects who underwent physical examination in the clinic during the same period were selected as control group.Flow cytometry was used to determine the percentages of CD3+T lymphocytes, CD4+and CD8+T lymphocytes, and CD4+CD25+regulatory T cells (Tregs) in peripheral blood, as well as CD4+/ CD8+ratio, and the three groups were compared in this regard by analysis of variance.Results Compared with the control group and CHB group, the liver failure group had a significantly decreased percentage of CD3+T lymphocytes in peripheral blood (34.12% ± 22.33% vs 50.31% ± 12.09% and 49.72% ± 20.11%, P < 0.05) , a significantly increased CD4+/ CD8+ratio (1.78 ± 1.25 vs 1.32 ± 0.31 and 1.31 ± 0.52, P < 0.05) , and a significantly decreased percentage of CD4+CD25+Tregs in peripheral blood (0.83% ± 1.00% vs 2.93% ± 1.31% and 3.17% ± 2.29%, P < 0.05) .Conclusion Once HBV- ACLF develops, T lymphocyte cells in peripheral blood and related effector T lymphocytes are“exhausted”, which reveals that the characteristics of its pathogenesis is“deficiency of vital qi”.
- liver failure /
- hepatitis B, chronic /
- T lymphocyte /
- TCM WM THERAPY

HTML全文

参考文献(16)

[1]YIN SP, GUO Q, JIANG Y, et al.Clinical study of lamivudine in the treatment of acute-on-chronic liver failure patients caused by hepatitis B[J].China Med Herald, 2012, 9 (17) :182-183. (in Chinese) 阴生平, 郭堑, 蒋茵, 等.拉米夫定治疗慢性乙型肝炎引起的慢加急性肝衰竭患者的临床研究[J].中国医药导报, 2012, 9 (17) :182-183.

[2]ZHANG Y, TAN SZ.The research progress in etiological and pathogenetic characteristics of Chinese medicine on chronic severe hepatitis/liver failure[J].Chin J Integr Tradit West Med Liver Dis, 2011, 21 (6) :380-383. (in Chinese) 张旸, 谭善忠.慢性重型肝炎/肝衰竭的中医病因病机特点研究进展[J].中西医结合肝病杂志, 2011, 21 (6) :380-383.

[3]SHI WL, SUN YQ, ZHANG T.The ideas and methods of triple factors Chinese medicine in mechanism of prevention and treatment on hepatitis B-liver failure[J].J Tradit Chin Med, 2011, 52 (5) :389-391. (in Chinese) 史文丽, 孙永强, 张弢.中医药防治乙型肝炎肝功能衰竭发生机制中三重因素的思路和方法[J].中医杂志, 2011, 52 (5) :389-391.

[4]ZHUANG QJ, QIU LM, YAO XS, et al.CD4+CD25+regulatory T cells and hepatitis B virus infection[J].World Chin J Dig, 2012, 20 (24) :2248-2253. (in Chinese) 庄勤建, 邱隆敏, 姚新生, 等.CD4+CD25+调节性T细胞与乙型肝炎病毒感染的研究进展[J].世界华人消化杂志, 2012, 20 (24) :2248-2253.

[5] WU YY, TAN SZ.The researches on the role of CD4+CD25+tregs in the pathogenesis of chronic hepatitis B[J].Chin J Infect Dis, 2012, 30 (9) :563-565. (in Chinese) 吴银亚, 谭善忠.CD4+CD25+调节性T淋巴细胞在慢性乙型肝炎发病机制中的作用[J].中华传染病杂志, 2012, 30 (9) :563-565.

[6]Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA;Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, CMA.Guideline for diagnosis and treatment of liver failure[J/CD].Chin J Transplant:Electronic Edition, 2013, 7 (1) :48-56. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J/CD].中华移植杂志:电子版, 2013, 7 (1) :48-56.

[7] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :1-15. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :1-15.

[8]ZENG ZL, WU JL, WU JZ.Detection of proportions of lymphocyte T subsets in peripheral blood and levels of Th1/Th2 cytokines in patients with hepatis B virus infection and its dinical significance[J].J Jilin Univ:Med Edit, 2012, 38 (3) :555-558. (in Chinese) 曾志励, 吴健林, 吴继周.乙型肝炎患者外同血T淋巴细胞亚群比例和Th1/Th2细胞因子水平检测及其临床意义[J].吉林大学学报:医学版, 2012, 38 (3) :555-558.

[9]SUN XH, LIU QL, LI M, et al.The study of CD4+and CD8+T subsets in chronic hepatitis B patients[J].Chin J Cell Mol Immunol, 2011, 27 (5) :545-547. (in Chinese) 孙学华, 刘巧丽, 李曼, 等.慢性乙型肝炎患者CD4+和CD8+T细胞亚群的研究[J].细胞与分子免疫学杂志, 2011, 27 (5) :545-547.

[10]DENG M, LI MH, LIU SA, et al.Studies about the level of CD4+CD25+regulatory T cells and relation between expression of Foxp3and CD127 in peripheral blood of chronic HBV infection[J].Chinese J Exp Clin Virol, 2010, 24 (1) :21-23. (in Chinese) 邓敏, 李明慧, 刘顺爱, 等.慢性HBV感染者调节性T细胞水平及Foxp3与CD127表达关系的研究[J].中华实验和临床病毒学杂志, 2010, 24 (1) :21-23.

[11]NAN XP, ZHANG Y, YU HT, et al.Circulating CD4+CD25+high regulatory T cells and expression of PD-1 and BTLA on CD4+T cells in patients with chronic hepatitis B virus infection[J].Viral Immunol, 2010, 23 (1) :63-70.

[12]WU YY, TAN SZ, ZHAO L.et al.The changes and value of the proportion of CD4+CD25+regulatory T cells in HBeAg (+) and HBeAg (-) ASC in peripheral blood[J].J Clin Hepatol, 2012, 28 (3) :209-211. (in Chinese) 吴银亚, 谭善忠, 赵磊, 等.HBeAg (+) 与HBeAg (-) 乙型肝炎病毒携带者外周血CD4+CD25+调节性T淋巴细胞比例的变化及意义[J].临床肝胆病杂志, 2012, 28 (3) :209-211.

[13]ZHANG H, HUANG LX, CHEN CX, et al.Effect of CD4+CD25+Foxp3+regulatory T cells on acute-on-chronic liver failure caused by hepatitis B infection[J].J Southeast Univ:Med Sci Edi, 2011, 30 (2) :315-318. (in Chinese) 张慧, 黄丽霞, 陈朝霞, 等.CD4+CD25+Foxp3+Treg细胞在HBV感染所致慢加急性肝衰竭中作用[J].东南大学学报:医学版, 2011, 30 (2) :315-318.

[14]YANG J, YI P, WEI L, et al.Phenotypes and clinical significance of circulating CD4+CD25+regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF) [J].J Transl Med, 2012, 10 (1) :193.

[15]SHI F, ZHANG JY, ZENG Z, et al.Skewed ratios between CD3 (+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure[J].Biochem Biophys Res Commun, 2010, 402 (1) :30-36.

[16]ZHANG Y, WU YY, TAN SZ, et al.Clinical observation on chronic severe hepatitis B treated by principle of strengthening vital Qi and the spleen based on the mechanism of deficiency in vital Qi[J].JETCM, 2012, 21 (6) :872-873, 892. (in Chinese) 张旸, 吴银亚, 谭善忠, 等.基于正虚机制观察益气健脾法治疗慢性乙型肝炎肝衰竭的临床疗效[J].中国中医急症, 2012, 21 (6) :872-873, 892.

施引文献

资源附件(0)

访问统计